On this page of StockholderLetter.com we present the latest annual shareholder letter from REPLIGEN CORP — ticker symbol RGEN. Reading current and past RGEN letters to shareholders can bring important insights into the investment thesis.
0102 455647 89 8
42567829 012 0 0 1) 3 (* 2 " * 0)+ .&"
34546749 3454674" * / ""446 4 ! 7% ) * 4 4 + ,6 4 4-.454 / 70 4 4 1 & 4 *46 56 44 ! 7% . 76% 4 ! $4 #6 + + 9 34 4 3454674 6 6 ! 6 "# $ 6 % & '7 4 # 4 6$ $ 64( 6 6 &%27 4 3 4 * &6 1 % ! "
 • shareholder letter icon 4/2/2026 Letter Continued (Full PDF)
 • stockholder letter icon 4/11/2023 RGEN Stockholder Letter
 • stockholder letter icon 4/1/2024 RGEN Stockholder Letter
 • stockholder letter icon 4/4/2025 RGEN Stockholder Letter
 • stockholder letter icon More "Biotechnology" Category Stockholder Letters
 • Benford's Law Stocks icon RGEN Benford's Law Stock Score = 74


RGEN Shareholder/Stockholder Letter Transcript:

0102  455647  89 8

  42567829  
012








0
0

1)

3

(*       2  "   *  0)+         .&"


34546749   

3454674" *
/ ""446    4 !  7%  
) *  4 4 
+   ,6 4   4-.454 
/ 70 4   4     1
&  4  *46 
56
44 !  7% . 76% 4 
! $4  #6
+  + 9   
    34   4 3454674  6     6  
    !  6   "# $ 6 %
& '7  4 # 4   6$
  $ 64(  6  6
&%27 4 3   4 *
&6  1  % !  "


shareholder letter icon 4/2/2026 Letter Continued (Full PDF)
 

RGEN Stockholder/Shareholder Letter (REPLIGEN CORP) | www.StockholderLetter.com
Copyright © 2023 - 2026, All Rights Reserved

Nothing in StockholderLetter.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy.